FindTrial
Sign In

The efficacy of epidual anesthesia for the prevention of intraoperative nausea and vomitting during elective cesarean section

The efficacy of epidual anesthesia for the prevention of intraoperative nausea and vomitting during elective cesarean section under combined epidural and spinal anesthesia - Epidural anesthesia for prevention of intraoperative nausea during C-sec

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT1091220398
Enrollment
90
Registered
2018-11-27
Start date
2019-01-07
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

elective cesarean section

Interventions

Intervention type:DRUG Name of intervention:Epidural administration of 2% mepivacaine Dose form / Japanese Medical Device Nomenclature:INJECTION Route of administration / Site of application:EPIDURAL

Sponsors

Uonuma Kikan Hospital Department of Anesthesiology Takayuki Kita
Lead Sponsor
Kenta Furutani Uonuma Kikan Hospital Department of Anesthesiology Hiroshi Baba Division of Anesthesiology, Niigata University Graduate School of Medical and Dental Sciences
Collaborator

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: .patients with ASA-PS 1or2 scheduled for elective cesarean section .Patients with BMI<35kg/m2 .Patients who agree with CSEA .Patients with written informed consent after enough description

Exclusion criteria

Exclusion criteria: .patients who undergo an emergency cesarean section .patients who undergo C-sec under spinal anesthesia only or general anesthesia .contraindicated cases for spinal anesthesia and epidual anesthesia:abnormalities of the coagulation system, anticoagulants and anti-platelet drugs medication .patients with BMI over 35kg/m2 .patients who have neurological abnormalities on lower extremities .patients who have abnormalities of spine .Patients who are not appropriate to participate in the trial

Design outcomes

Primary

MeasureTime frame
frequency of nausea and vomiting during surgery—

Secondary

MeasureTime frame
The degree of pain and nausea during and after surgery,motor function of legs after surgery—

Countries

Japan

Contacts

Public ContactTakayuki Kita

Uonuma Kikan Hospital

takayuki19790924@yahoo.co.jp+81-25-777-3200

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026